[1]
Iwanski J, Knapp SM, Avery R, Oliva I, Wong RK, Runyan RB, Khalpey Z. Clinical outcomes meta-analysis: measuring subendocardial perfusion and efficacy of transmyocardial laser revascularization with nuclear imaging. Journal of cardiothoracic surgery. 2017 May 19:12(1):37. doi: 10.1186/s13019-017-0602-8. Epub 2017 May 19
[PubMed PMID: 28526044]
Level 2 (mid-level) evidence
[2]
Iwanski J, Wong RK, Larson DF, Ferng AS, Runyan RB, Goldstein S, Khalpey Z. Remodeling an infarcted heart: novel hybrid treatment with transmyocardial revascularization and stem cell therapy. SpringerPlus. 2016:5(1):738. doi: 10.1186/s40064-016-2355-6. Epub 2016 Jun 16
[PubMed PMID: 27376006]
[3]
Konstanty-Kalandyk J, Bartuś K, Piątek J, Vuddanda V, Lee R, Kędziora A, Sadowski J, Lakkireddy D, Kapelak B. Midterm outcomes of transmyocardial laser revascularization with intramyocardial injection of adipose derived stromal cells for severe refractory angina. Postepy w kardiologii interwencyjnej = Advances in interventional cardiology. 2018:14(2):176-182. doi: 10.5114/aic.2018.76409. Epub 2018 Jun 19
[PubMed PMID: 30008770]
Level 3 (low-level) evidence
[4]
Kindzelski BA, Zhou Y, Horvath KA. Transmyocardial revascularization devices: technology update. Medical devices (Auckland, N.Z.). 2015:8():11-9. doi: 10.2147/MDER.S51591. Epub 2014 Dec 18
[PubMed PMID: 25565905]
[5]
Manchanda A, Aggarwal A, Aggarwal N, Soran O. Management of refractory angina pectoris. Cardiology journal. 2011:18(4):343-51
[PubMed PMID: 21769814]
[6]
Sobczak M, Kasprzak JD. [Cardiac shock wave therapy--a new method for treatment of advanced coronary disease and refractory angina]. Kardiologia polska. 2010 Dec:68(12):1391-6
[PubMed PMID: 21174300]
[7]
Lauer B, Stahl F, Bratanow S, Schuler G. [Percutaneous myocardial laser revascularization (PMR), a new therapeutic procedure for patients with refractory angina pectoris]. Zeitschrift fur Kardiologie. 2000:89 Suppl 7():31-6
[PubMed PMID: 11098557]
[8]
Fihn SD, Gardin JM, Abrams J, Berra K, Blankenship JC, Dallas AP, Douglas PS, Foody JM, Gerber TC, Hinderliter AL, King SB 3rd, Kligfield PD, Krumholz HM, Kwong RY, Lim MJ, Linderbaum JA, Mack MJ, Munger MA, Prager RL, Sabik JF, Shaw LJ, Sikkema JD, Smith CR Jr, Smith SC Jr, Spertus JA, Williams SV, American College of Cardiology Foundation, American Heart Association Task Force on Practice Guidelines, American College of Physicians, American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, Society of Thoracic Surgeons. 2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS Guideline for the diagnosis and management of patients with stable ischemic heart disease: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, and the American College of Physicians, American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. Journal of the American College of Cardiology. 2012 Dec 18:60(24):e44-e164. doi: 10.1016/j.jacc.2012.07.013. Epub 2012 Nov 19
[PubMed PMID: 23182125]
Level 1 (high-level) evidence
[9]
Briones E, Lacalle JR, Marin-Leon I, Rueda JR. Transmyocardial laser revascularization versus medical therapy for refractory angina. The Cochrane database of systematic reviews. 2015 Feb 27:2015(2):CD003712. doi: 10.1002/14651858.CD003712.pub3. Epub 2015 Feb 27
[PubMed PMID: 25721946]
Level 1 (high-level) evidence
[10]
Schofield PM, McNab D, National Institute for Health and Clinical. NICE evaluation of transmyocardial laser revascularisation and percutaneous laser revascularisation for refractory angina. Heart (British Cardiac Society). 2010 Feb:96(4):312-3. doi: 10.1136/hrt.2009.185769. Epub
[PubMed PMID: 20194211]
[11]
Amritphale A, Amritphale N. Refractory Angina: the Current State of Mechanical Therapies. Current cardiology reports. 2019 Apr 22:21(6):46. doi: 10.1007/s11886-019-1134-8. Epub 2019 Apr 22
[PubMed PMID: 31011835]
[12]
Soran O. Alternative therapy for medically refractory angina: enhanced external counterpulsation and transmyocardial laser revascularization. Cardiology clinics. 2014 Aug:32(3):429-38. doi: 10.1016/j.ccl.2014.04.009. Epub
[PubMed PMID: 25091968]
[13]
Lanza GA, Manzoli A, Pasceri V, Colonna G, Cianflone D, Crea F, Maseri A. Ischemic-like ST-segment changes during Holter monitoring in patients with angina pectoris and normal coronary arteries but negative exercise testing. The American journal of cardiology. 1997 Jan 1:79(1):1-6
[PubMed PMID: 9024726]
[14]
Kloner RA, Chaitman B. Angina and Its Management. Journal of cardiovascular pharmacology and therapeutics. 2017 May:22(3):199-209. doi: 10.1177/1074248416679733. Epub 2016 Dec 14
[PubMed PMID: 28196437]
[15]
Tousoulis D, Androulakis E, Kontogeorgou A, Papageorgiou N, Charakida M, Siama K, Latsios G, Siasos G, Kampoli AM, Tourikis P, Tsioufis K, Stefanadis C. Insight to the pathophysiology of stable angina pectoris. Current pharmaceutical design. 2013:19(9):1593-600
[PubMed PMID: 23016715]
[16]
Agarwal S, Kamath MV, Castresana MR. Transesophageal echocardiography for transmyocardial laser revascularization. Anesthesia and analgesia. 2014 May:118(5):1146-9
[PubMed PMID: 24895765]
[17]
Sansone F, Dato GM, Zingarelli E, Punta G, Parisi F, Forsennati PG, Flocco R, Bardi GL, Ponte SD, Casabona R. Late angiograms ten years after transmyocardial laser revascularization. Coronary artery disease. 2011 Dec:22(8):583-4. doi: 10.1097/MCA.0b013e32834c7534. Epub
[PubMed PMID: 21959715]
[18]
Akay MH, Cheong BY, Frazier OH. Use of magnetic resonance imaging to assess myocardial perfusion after transmyocardial laser revascularization. The heart surgery forum. 2009 Aug:12(4):E199-201. doi: 10.1532/HSF98.20081090. Epub
[PubMed PMID: 19683988]
[19]
Hamman BL, White CH, Cheung EH, Hebeler RF, Kourlis H Jr, Meyers TP, Wood RE, Lansing AM. Transmyocardial laser revascularization causes sustained VEGF secretion. Seminars in thoracic and cardiovascular surgery. 2006 Spring:18(1):43-5
[PubMed PMID: 16766253]
[20]
Allen KB, Kelly J, Borkon AM, Stuart RS, Daon E, Pak AF, Zorn GL, Haines M. Transmyocardial laser revascularization: from randomized trials to clinical practice. A review of techniques, evidence-based outcomes, and future directions. Anesthesiology clinics. 2008 Sep:26(3):501-19. doi: 10.1016/j.anclin.2008.04.001. Epub
[PubMed PMID: 18765220]
Level 3 (low-level) evidence
[21]
Horvath KA. Transmyocardial laser revascularization. Journal of cardiac surgery. 2008 May-Jun:23(3):266-76. doi: 10.1111/j.1540-8191.2008.00579.x. Epub
[PubMed PMID: 18435649]
[22]
Konstanty-Kalandyk J, Piątek J, Kędziora A, Bartuś K, Drwila R, Darocha T, Filip G, Kapelak B, Song BH, Sadowski J. Ten-year follow-up after combined coronary artery bypass grafting and transmyocardial laser revascularization in patients with disseminated coronary atherosclerosis. Lasers in medical science. 2018 Sep:33(7):1527-1535. doi: 10.1007/s10103-018-2514-9. Epub 2018 May 7
[PubMed PMID: 29732521]
[23]
Qu Z, Zheng JB, Zhang ZG. Single-center report of 5-year follow-up on 94 patients underwent transmyocardial laser revascularization. Chinese medical journal. 2007 Nov 20:120(22):1982-5
[PubMed PMID: 18067782]
[24]
Hughes GC, Landolfo KP, Lowe JE, Coleman RB, Donovan CL. Perioperative morbidity and mortality after transmyocardial laser revascularization: incidence and risk factors for adverse events. Journal of the American College of Cardiology. 1999 Mar 15:33(4):1021-6
[PubMed PMID: 10091830]
[25]
Tjomsland O, Aaberge L, Almdahl SM, Dragsund M, Moelstad P, Saatvedt K, Nordstrand K. Perioperative cardiac function and predictors for adverse events after transmyocardial laser treatment. The Annals of thoracic surgery. 2000 Apr:69(4):1098-103
[PubMed PMID: 10800800]
[26]
Misfeld M, Gerriets T, Kopiske G, Kaps M, Sievers HH, Kraatz EG. Quantification of microembolic signals during transmyocardial laser revascularization. Interactive cardiovascular and thoracic surgery. 2003 Sep:2(3):334-8
[PubMed PMID: 17670061]